Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice
Diabetic hepatopathy is a serious complication of poorly controlled diabetes mellitus. An efficient antidiabetic drug which keeps normal liver tissues is not available. The renin-angiotensin system has been re...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Amal M. Mahfoz and Aya Y. Gawish Tags: Research Source Type: research
More News: Diabetes | Diabetes Mellitus | Endocrinology | Liver | Liver Disease | Metabolic Syndrome | Tekturna | Urology & Nephrology